These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

435 related items for PubMed ID: 18285494

  • 21. Selection and evaluation of the immunogenicity of protective antigen mutants as anthrax vaccine candidates.
    Yan M, Roehrl MH, Basar E, Wang JY.
    Vaccine; 2008 Feb 13; 26(7):947-55. PubMed ID: 18192092
    [Abstract] [Full Text] [Related]

  • 22. Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen.
    Boyaka PN, Tafaro A, Fischer R, Leppla SH, Fujihashi K, McGhee JR.
    J Immunol; 2003 Jun 01; 170(11):5636-43. PubMed ID: 12759444
    [Abstract] [Full Text] [Related]

  • 23. BA3338, a surface layer homology domain possessing protein augments immune response and protection efficacy of protective antigen against Bacillus anthracis in mouse model.
    Kumar M, Puranik N, Varshney A, Tripathi N, Pal V, Goel AK.
    J Appl Microbiol; 2020 Aug 01; 129(2):443-452. PubMed ID: 32118336
    [Abstract] [Full Text] [Related]

  • 24. Development of a novel multiepitope chimeric vaccine against anthrax.
    Aggarwal S, Somani VK, Gupta S, Garg R, Bhatnagar R.
    Med Microbiol Immunol; 2019 Apr 01; 208(2):185-195. PubMed ID: 30671633
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Development of a multiple-antigen protein fusion vaccine candidate that confers protection against Bacillus anthracis and Yersinia pestis.
    Gallagher TB, Mellado-Sanchez G, Jorgensen AL, Moore S, Nataro JP, Pasetti MF, Baillie LW.
    PLoS Negl Trop Dis; 2019 Aug 01; 13(8):e0007644. PubMed ID: 31430284
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A new triple chimeric protein as a high immunogenic antigen against anthrax toxins: theoretical and experimental analyses.
    Abdous M, Hasannia S, Salmanian AH, Shahryar Arab S, Shali A, Alizadeh GA, Hajizadeh A, Khafri A, Mohseni A.
    Immunopharmacol Immunotoxicol; 2019 Feb 01; 41(1):25-31. PubMed ID: 30621469
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. An anthrax subunit vaccine candidate based on protective regions of Bacillus anthracis protective antigen and lethal factor.
    Baillie LW, Huwar TB, Moore S, Mellado-Sanchez G, Rodriguez L, Neeson BN, Flick-Smith HC, Jenner DC, Atkins HS, Ingram RJ, Altmann DM, Nataro JP, Pasetti MF.
    Vaccine; 2010 Sep 24; 28(41):6740-8. PubMed ID: 20691267
    [Abstract] [Full Text] [Related]

  • 31. Recombinant vaccine displaying the loop-neutralizing determinant from protective antigen completely protects rabbits from experimental inhalation anthrax.
    Oscherwitz J, Yu F, Jacobs JL, Cease KB.
    Clin Vaccine Immunol; 2013 Mar 24; 20(3):341-9. PubMed ID: 23283638
    [Abstract] [Full Text] [Related]

  • 32. Enhanced Immune Response to DNA Vaccine Encoding Bacillus anthracis PA-D4 Protects Mice against Anthrax Spore Challenge.
    Kim NY, Chang DS, Kim Y, Kim CH, Hur GH, Yang JM, Shin S.
    PLoS One; 2015 Mar 24; 10(10):e0139671. PubMed ID: 26430894
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Surface plasmon resonance measurements of plasma antibody avidity during primary and secondary responses to anthrax protective antigen.
    Lynch HE, Stewart SM, Kepler TB, Sempowski GD, Alam SM.
    J Immunol Methods; 2014 Feb 24; 404():1-12. PubMed ID: 24316020
    [Abstract] [Full Text] [Related]

  • 35. Generation of protective immune response against anthrax by oral immunization with protective antigen plant-based vaccine.
    Gorantala J, Grover S, Rahi A, Chaudhary P, Rajwanshi R, Sarin NB, Bhatnagar R.
    J Biotechnol; 2014 Apr 20; 176():1-10. PubMed ID: 24548460
    [Abstract] [Full Text] [Related]

  • 36. Nasal immunization with the mixture of PA63, LF, and a PGA conjugate induced strong antibody responses against all three antigens.
    Sloat BR, Shaker DS, Le UM, Cui Z.
    FEMS Immunol Med Microbiol; 2008 Mar 20; 52(2):169-79. PubMed ID: 18194342
    [Abstract] [Full Text] [Related]

  • 37. Potentiation of an anthrax DNA vaccine with electroporation.
    Luxembourg A, Hannaman D, Nolan E, Ellefsen B, Nakamura G, Chau L, Tellez O, Little S, Bernard R.
    Vaccine; 2008 Sep 19; 26(40):5216-22. PubMed ID: 18462850
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. A bivalent protein r-PB, comprising PA and BclA immunodominant regions for comprehensive protection against Bacillus anthracis.
    Majumder S, Das S, Somani V, Makam SS, Joseph KJ, Bhatnagar R.
    Sci Rep; 2018 May 08; 8(1):7242. PubMed ID: 29740033
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.